SCHEMBL19086438

SCHEMBL19086438

CN(CCNc1ccc(I)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
MAOA P21397 1/20 0.37
CNR1 P21554 1/20 0.37
DRD4 P21917 1/20 0.37
ACHE P22303 1/20 0.37
HRH2 P25021 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
MAPK1 P28482 1/20 0.37
NTSR1 P30989 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
SCN1A P35498 1/20 0.37
HTR2B P41595 1/20 0.37
SCN7A Q01118 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
SCN5A Q14524 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20873910 0.85 RAB9A (0.41) POLBLMNACYP1A2MAOACNR1
SCHEMBL17572258 0.79 FPR3 (0.43) LMNACYP1A2MAOACNR1DRD4
SCHEMBL22804306 0.74 L3MBTL1 (0.39) HTR2AHTR2CRAB9ANPC1TPMT
SCHEMBL20762355 0.74 CA12 (0.43) POLBHRH3FPR2RAB9ANPC1
SCHEMBL19086455 0.73 GAA (0.48) ACHEFPR2KDM4EMAPT
SCHEMBL23121013 0.73 POLB (0.59) POLBKDM4EBLMTPMTMAPT
SCHEMBL1831611 0.72 ALDH1A1 (0.45) ACHERAB9ANPC1MTORMAPT
SCHEMBL22837861 0.72 DRD3 (0.44) POLBLMNACYP1A2MAOACNR1
SCHEMBL27823638 0.72 POLB (0.45) POLBFPR2MAPTTRPV1
SCHEMBL4474317 0.72 MAPT (0.43) POLBFPR2KDM4ETPMTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190111-B1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (CN) 2020-05-06 EP disclosed
US-9975893-B2 Pyrazolo[3,4-c]pyridine derivatives CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2018-05-22 US disclosed
US-20170291896-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2017-10-12 US disclosed
EP-3190111-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170291896-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES F11, TFPI, F2 POLB 2890/4885LMNA 429/4885CYP1A2 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.